Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-27 @ 11:00 PM
Study NCT ID:
NCT06305234
Status:
RECRUITING
Last Update Posted:
2024-08-26
First Post:
2024-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
Sponsor:
BioMarin Pharmaceutical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2033-11-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-11-18
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-30
First Submit QC Date:
None
Study First Post Date:
2024-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-23
Last Update Post Date:
2024-08-26
Last Update Post Date Type:
ACTUAL